Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 554-559

  Hartmann, K ^a   Hermes, B ^b   Rappersberger, K ^c   Sepp, N ^d   Mekori, Y A ^e   Henz, B M ^f  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Vivantes Klinikum Prenzlauer Berg   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e HUMBOLDT UNIVERSITY   (Germany)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Mast cells; Mastocytoma; Mastocytosis; p53; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; MONOCLONAL ANTIBODY KI 67; PROTEIN P21; PROTEIN P53; TOLONIUM CHLORIDE; TUMOR SUPPRESSOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MAST CELL; MASTOCYTOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; STAINING; TISSUE SECTION; URTICARIA PIGMENTOSA;

ADOLESCENT; ADULT; APOPTOSIS; CELL DIVISION; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; KI-67 ANTIGEN; MAST CELLS; MASTOCYTOSIS; PROTO-ONCOGENE PROTEINS P21(RAS); SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0142057200     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05598.x     Document Type: Article

References (27)

1. Hartmann K, Henz BM. Mastocytosis: recent advances in defining the disease. Br J Dermatol 2001; 144: 682-95.
2. Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603-25.
3. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res 2002; 26: 483-4.
4. Henz BM. SCF and c-Kit in mastocytosis - a Pandora's box holding more theories than proven facts. J Invest Dermatol 1998; 110: 186 (Letter).
5. Hartmann K, Metcalfe DD. Regulation and dysregulation of mast cell survival and apoptosis. In: Mast Cells and Basophils in Physiology, Pathology and Host Defense (Marone G, Lichtenstein LM, Galli SJ, eds). San Diego: Academic Press, 2000; 51-60.
6. Büttner C, Henz BM, Sepp N, Grabbe J. Identification of an activating c-kit mutation in adult but not in childhood onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998; 111: 1227-31.
7. Haas N, Toppe E, Henz BM. Microscopic morphology in different types of urticaria. Arch Dermatol 1998; 134: 41-6.
8. Hermes B, Prochazka AK, Haas N et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1991; 103: 307-14.
9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
10. Mekori YA, Oh CK, Metcalfe DD. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 1993; 151: 3775-84.
11. Mekori YA, Gilfillan AM, Akin C et al. Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol 2001; 21: 171-4.
12. Longley BJ, Morganroth GS, Tyrell L et al. Altered metabolism of mast cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993; 328: 1302-7.
13. Wunderlich M, Berberich SJ. Mdm2 inhibition of p53 induces E2F1 transactivation via p21. Oncogene 2002; 21: 4414-21.
14. Xu D, Finkel T. A role for mitochondria as potential regulators of cellular life span. Biochem Biophys Res Commun 2002; 294: 245-8.
15. Hsieh J, Kletsas D, Clunn G et al. P53, p21 (WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 636-44.
16. Ussat S, Werner UE, Kruse ML et al. Upregulation of p21 (WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell death. Biochem Biophys Res Commun 2002; 194: 672-9.
17. Lee JM. Inhibition of p53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species. Oncogene 1998; 17: 1653-62.
18. Kibbe MR, Tzeng E. Nitric oxide synthase gene therapy in vascular pathology. Semin Perinatal 2000; 24: 51-4.
19. Townsend PA, Villanova I, Uhlmann E et al. An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur J Cancer 2000; 36: 397-409.
20. Hartmann K, Zirbes TK, Hasan S et al. Expression of anti-apoptotic protein bcl-x in human mast cells and mastocytosis. J Allergy Clin Immunol 2000; 105: S66 (Abstr.).
21. Hartmann K, Artuc M, Hermes B et al. Altered regulation of apoptosis in cutaneous mastocytosis. J Invest Dermatol 2001; 117: 803 (Abstr.).
22. Jordan JH, Walchshofer S, Jurecka W et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-xL. Hum Pathol 2001; 32: 545-52.
23. Cevero C, Escribano L, San Miguel JF et al. Expression of bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol 1999; 60: 191-5.
24. Duronio V, Welham MJ, Abraham S et al. P21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTP-activating protein. Proc Natl Acad Sci USA 1992; 89: 1587-91.
25. Yee NS, Peak I, Besmer P. Role of kit-ligand in proliferation and suppression of apoptosis in mast cell: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 1994; 179: 1777-87.
26. Ginn PE, Fox LF, Brower JC et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000; 37: 33-9.
27. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84: 2391-411.